Maravai LifeSciences Holdings, Inc. Costs and Expenses
Maravai LifeSciences Holdings, Inc. (MRVI) reported Costs and Expenses of $35.74 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. costs and expenses for the quarter ending 2026-06-30 was $35.74M, a 51.73% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. costs and expenses for the quarter ending 2026-03-31 was $35.86M, a 36.96% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. costs and expenses for the quarter ending 2025-12-31 was $71.64M, a 25.48% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. costs and expenses for the quarter ending 2025-09-30 was $46.69M, a 76.40% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. costs and expenses for fiscal 2025 was $249.26M, a 27.53% decline from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. costs and expenses for fiscal 2024 was $343.93M, a 100.13% increase from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. costs and expenses for fiscal 2023 was $171.85M, a 44.35% decline from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. costs and expenses for fiscal 2022 was $308.79M, a 26.24% increase from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 6 month as first filed | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $35.74M 10-Q · filed 2026-08-07 | $71.60M 10-Q · filed 2026-08-07 | $143.24M derived: sum of 3 quarters · filed 2026-08-07 | $189.92M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $35.86M 10-Q · filed 2026-05-08 | $107.50M derived: sum of 2 quarters · filed 2026-05-08 | $154.18M derived: sum of 3 quarters · filed 2026-05-08 | $228.23M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $71.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $118.32M derived: sum of 2 quarters · filed 2026-02-26 | $192.37M derived: sum of 3 quarters · filed 2026-08-07 | $249.26M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $46.69M 10-Q · filed 2025-11-07 | $120.73M derived: sum of 2 quarters · filed 2026-08-07 | $177.62M 10-Q · filed 2025-11-07 | $234.71M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $74.05M 10-Q · filed 2026-08-07 | $113.67M 10-Q · filed 2025-08-11 | $130.93M 10-Q · filed 2026-08-07 | $209.69M 10-Q · filed 2025-08-11 | $188.03M derived: sum of 3 quarters · filed 2026-08-07 | $385.87M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $56.89M 10-Q · filed 2026-05-08 | $96.01M 10-Q · filed 2025-05-12 | $113.98M derived: sum of 2 quarters · filed 2026-05-08 | $311.83M derived: sum of 3 quarters · filed 2026-05-08 | $394.69M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | $57.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $254.94M derived: sum of 2 quarters · filed 2026-02-26 | $337.80M derived: sum of 3 quarters · filed 2026-02-26 | $343.93M 10-K · filed 2026-02-26 | $494.80M 10-K · filed 2025-03-18 | |||
| 2024-09-30 | $197.85M 10-Q · filed 2025-11-07 | $234.31M 10-Q · filed 2024-11-12 | $280.71M derived: sum of 2 quarters · filed 2025-11-07 | $286.83M 10-Q · filed 2025-11-07 | $400.27M 10-Q · filed 2024-11-12 | $296.30M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $82.86M 10-Q · filed 2025-08-11 | $82.91M 10-Q · filed 2024-08-08 | $165.90M 10-Q · filed 2025-08-11 | $165.95M 10-Q · filed 2024-08-08 | $98.45M derived: sum of 3 quarters · filed 2026-02-26 | $180.73M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $83.04M 10-Q · filed 2025-05-12 | $15.59M derived: sum of 2 quarters · filed 2026-02-26 | $97.87M derived: sum of 3 quarters · filed 2026-02-26 | $178.40M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$67.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.83M derived: sum of 2 quarters · filed 2026-02-26 | $95.36M derived: sum of 3 quarters · filed 2026-02-26 | $171.85M 10-K · filed 2026-02-26 | $320.59M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $82.28M 10-Q · filed 2024-11-12 | $162.81M derived: sum of 2 quarters · filed 2024-11-12 | $239.30M 10-Q · filed 2024-11-12 | $334.77M derived: sum of 4 quarters · filed 2025-03-18 | ||||
| 2023-06-30 | $80.53M 10-Q · filed 2024-08-08 | $157.02M 10-Q · filed 2024-08-08 | $252.49M derived: sum of 3 quarters · filed 2025-03-18 | $326.85M derived: sum of 4 quarters · filed 2025-03-18 | ||||
| 2023-03-31 | $76.49M 10-Q · filed 2024-05-09 | $171.96M derived: sum of 2 quarters · filed 2025-03-18 | $246.32M derived: sum of 3 quarters · filed 2025-03-18 | $308.35M derived: sum of 4 quarters · filed 2025-03-18 | ||||
| 2022-12-31 | $95.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $169.83M derived: sum of 2 quarters · filed 2025-03-18 | $231.86M derived: sum of 3 quarters · filed 2025-03-18 | $308.79M 10-K · filed 2025-03-18 | ||||
| 2022-09-30 | $74.36M 10-Q · filed 2023-11-08 | $136.39M derived: sum of 2 quarters · filed 2023-11-08 | $213.32M 10-Q · filed 2023-11-08 | $287.22M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $62.03M 10-Q · filed 2023-08-08 | $138.96M 10-Q · filed 2023-08-08 | $212.86M derived: sum of 3 quarters · filed 2024-02-29 | $262.29M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $76.93M 10-Q · filed 2023-05-09 | $150.83M derived: sum of 2 quarters · filed 2024-02-29 | $200.26M derived: sum of 3 quarters · filed 2024-02-29 | $264.50M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $73.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $123.33M derived: sum of 2 quarters · filed 2024-02-29 | $187.57M derived: sum of 3 quarters · filed 2024-02-29 | $244.59M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $49.43M 10-Q · filed 2022-11-04 | $47.94M 10-Q · filed 2021-11-15 | $113.67M derived: sum of 2 quarters · filed 2022-11-04 | $170.69M 10-Q · filed 2022-11-04 | $167.24M 10-Q · filed 2021-11-15 | $237.80M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $64.24M 10-Q · filed 2022-08-05 | $63.53M 10-Q · filed 2021-08-11 | $121.26M 10-Q · filed 2022-08-05 | $119.30M 10-Q · filed 2021-08-11 | $188.37M derived: sum of 3 quarters · filed 2023-02-28 | $230.51M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $57.02M 10-Q · filed 2022-05-06 | $55.77M 10-Q · filed 2021-05-12 | $124.13M derived: sum of 2 quarters · filed 2023-02-28 | $166.27M derived: sum of 3 quarters · filed 2023-02-28 | $205.05M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $67.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $109.25M derived: sum of 2 quarters · filed 2023-02-28 | $148.03M derived: sum of 3 quarters · filed 2023-02-28 | $164.20M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $42.14M 10-Q · filed 2021-11-15 | $80.92M derived: sum of 2 quarters · filed 2021-11-15 | $97.09M 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | $38.78M 10-Q · filed 2021-08-11 | $54.95M 10-Q · filed 2021-08-11 | ||||||
| 2020-03-31 | $16.16M 10-Q · filed 2021-05-12 | |||||||
| 2019-12-31 | $119.15M 10-K · filed 2022-03-01 |